RSS
Sitemap
Login (HMA-DMS)
Contact
Search
About HMA
Human Medicines
Veterinary Medicines
You are here:
Home
>
Human Medicines
>
CMDh
>
Pharmacovigilance
>
PSUR
>
Informal PSUR Worksharing
CMDh
About CMDh
Statistics
Agendas and Minutes
Press Releases
COVID-19
BREXIT
Nitrosamine impurities
Procedural Guidance
CMDh-Referrals
Product Information
Advice from CMDh
Templates
CMD Working Parties / Working Groups
Paediatric Regulation
Pharmacovigilance
General Information
Referrals
PSUR
PSUR Single Assessment
Informal PSUR Worksharing
Outcome of informal PSUR worksharing procedures
PSUSA Follow-up
Outcome of PSUR Follow-up procedures
PSUR Work Sharing and Synchronisation Project
RMP
Article 57
Falsified Medicines
Questions & Answers
Contact Points
Recently Published history
MRI Product Index
Pharmacovigilance
Availability of Medicines
Publications and reports
National Contacts
Informal
PSUR
Worksharing
Best Practice Guide on (1) Introduction of substances/combinations onto the EURD list and setting the initial PSUR DLP and frequency and (2) Assessment of PSURs of products where the EU Reference Date is not yet legally binding
(May 2023) [
Track version
]
Template - PSUR Assessment Report
